Figure 1From: A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: Design and statistical methods of the PERSEUS clinical program PERSEUS WH and PERSEUS SV Study Schematic.Back to article page